HUT64222A - Process for producing gastric acid secretion preventive and gastrocitoprotective medical preparation - Google Patents
Process for producing gastric acid secretion preventive and gastrocitoprotective medical preparationInfo
- Publication number
- HUT64222A HUT64222A HU914068A HU406891A HUT64222A HU T64222 A HUT64222 A HU T64222A HU 914068 A HU914068 A HU 914068A HU 406891 A HU406891 A HU 406891A HU T64222 A HUT64222 A HU T64222A
- Authority
- HU
- Hungary
- Prior art keywords
- gastrocitoprotective
- preventive
- gastric acid
- acid secretion
- medical preparation
- Prior art date
Links
- 230000027119 gastric acid secretion Effects 0.000 title 1
- 230000003449 preventive effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/54—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU914068A HU210154B (en) | 1991-12-20 | 1991-12-20 | Process for producing new famotidin-salts and pharmaceutical compositions of gastro-acid-secretion-inhibiting and gastro-citoprotective activity, containing them |
| PCT/HU1992/000057 WO1993013076A1 (en) | 1991-12-20 | 1992-12-18 | Gastric acid secretion-inhibiting, and gastrocytoprotective pharmaceutical compositions, novel famotidine salts and process for preparing same |
| CN92113837.7A CN1074440A (zh) | 1991-12-20 | 1992-12-19 | 胃酸分泌抑制及胃细胞保护性药物组合物，新的法莫替丁(famotidinc)盐及其制备方法 |
| IL104185A IL104185A0 (en) | 1991-12-20 | 1992-12-20 | Gastric acid secretion-inhibiting and gastrocyto-protective pharmaceutical compositions,novel famotidine salts and process for preparing same |
| TW081110292A TW222260B (hu) | 1991-12-20 | 1992-12-21 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU914068A HU210154B (en) | 1991-12-20 | 1991-12-20 | Process for producing new famotidin-salts and pharmaceutical compositions of gastro-acid-secretion-inhibiting and gastro-citoprotective activity, containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU914068D0 HU914068D0 (en) | 1992-03-30 |
| HUT64222A true HUT64222A (en) | 1993-12-28 |
| HU210154B HU210154B (en) | 1995-02-28 |
Family
ID=10966774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU914068A HU210154B (en) | 1991-12-20 | 1991-12-20 | Process for producing new famotidin-salts and pharmaceutical compositions of gastro-acid-secretion-inhibiting and gastro-citoprotective activity, containing them |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN1074440A (hu) |
| HU (1) | HU210154B (hu) |
| IL (1) | IL104185A0 (hu) |
| TW (1) | TW222260B (hu) |
| WO (1) | WO1993013076A1 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0994104A4 (en) * | 1996-06-27 | 2001-09-12 | Ono Pharmaceutical Co | ARYL SULFIDE, SULFOXIDE AND SULPHONE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT |
| US9693942B2 (en) | 2012-03-30 | 2017-07-04 | Nestec S.A. | 4-oxo-2-pentenoic acid and skin pigmentation |
| US20150057349A1 (en) * | 2012-03-30 | 2015-02-26 | Nestec S.A. | 4-oxo-2-pentenoic acid and the health of the digestive tract |
| JP2015518371A (ja) * | 2012-03-30 | 2015-07-02 | ネステク ソシエテ アノニム | ４−オキソ−２−ペンテン酸及び肝臓障害 |
| EP2830611B1 (en) | 2012-03-30 | 2016-04-27 | Nestec S.A. | 4-oxo-2-pentenoic acid and brain health |
| JP6113265B2 (ja) * | 2012-03-30 | 2017-04-12 | ネステク ソシエテ アノニム | ４−オキソ−２−ペンテン酸及び心血管の健康 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9009240D0 (en) * | 1990-04-25 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
| US5068405A (en) * | 1990-07-06 | 1991-11-26 | Delmar Chemicals Inc. | Famotidine intermediates and their preparation |
| CA2052698A1 (en) * | 1990-10-11 | 1992-04-12 | Roger G. Berlin | Treatment of peptic ulcer |
-
1991
- 1991-12-20 HU HU914068A patent/HU210154B/hu not_active IP Right Cessation
-
1992
- 1992-12-18 WO PCT/HU1992/000057 patent/WO1993013076A1/en not_active Ceased
- 1992-12-19 CN CN92113837.7A patent/CN1074440A/zh active Pending
- 1992-12-20 IL IL104185A patent/IL104185A0/xx unknown
- 1992-12-21 TW TW081110292A patent/TW222260B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CN1074440A (zh) | 1993-07-21 |
| HU914068D0 (en) | 1992-03-30 |
| IL104185A0 (en) | 1993-05-13 |
| TW222260B (hu) | 1994-04-11 |
| HU210154B (en) | 1995-02-28 |
| WO1993013076A1 (en) | 1993-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9200767D0 (en) | Process for the inudstrialized mass production of standardized human willebrand-factor concentrate of high clarity for medical use | |
| HU9202145D0 (en) | Method for producing 7-aza-iso-indolinyl-quinolone derivatives and ones of naphtyridone-carboxylic acid and medical preparatives containing said compounds | |
| HU9201548D0 (en) | Process for the production of a medical composition | |
| HU9201518D0 (en) | Process for the production of a medical composition | |
| HU9202616D0 (en) | Method for preparing pharmaceutical preparatives serving for treatment of congestive heart diseases | |
| EP0548365A4 (en) | Process for producing implant | |
| HU914060D0 (en) | Medical preparation and process for its production | |
| HUT50473A (en) | Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds | |
| DE3466539D1 (en) | 4'-flavonecarboxylic acids, process for their preparation and their therapeutical use | |
| HUT64222A (en) | Process for producing gastric acid secretion preventive and gastrocitoprotective medical preparation | |
| CS543688A2 (en) | Method of pharmaceutical preparation that promotes wound healing | |
| AP9400676A0 (en) | Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-1h-indole-5-ethanesulphonamid-e and physiologically acceptable salts thereof | |
| HU9302201D0 (en) | Salts of 4-amino-3-acyl-quinoline derivatives and their application for hindering secretion of gastric acid | |
| HU9200008D0 (en) | Phenoxi-alkyl-carboxylic acid and process for producing it | |
| EP0543343A3 (en) | Process for the preparation of alpha-hydroxy-beta-aminocarboxylic acids | |
| EP0518013A3 (en) | Process for the preparation of 1-alkoxy-2-dialkylaminoethanes | |
| EP0469359A3 (en) | Method and product for the treatment of gastric disease | |
| GB9103134D0 (en) | Process for the preparation of n-acyl-alpha-amino acids | |
| HU911198D0 (en) | Process for the production of a medical preparation | |
| EP0515345A3 (en) | Preparation of malic acid | |
| EP0523668A3 (en) | Process for the preparation of difluorobenzaldehydes | |
| EP0523619A3 (en) | Process for the preparation of n-cyanimidocarbonates | |
| EP0504069A3 (en) | Process for preparing e-2-propyl-2-pentenoic acid and intermediate products | |
| EP0531826A3 (en) | Process for the preparation of carboxylic acid halides | |
| HU913310D0 (en) | Process for the production of medical preparations for treating psoreasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |